更正：曼苏尔等人。基于双增强普朗尼克纳米制剂的甲氨蝶呤乳腺癌治疗方法：体外和体内效率的开发与评估。2022年，，2668。 （注：原文中“2022, , 2668”表述似乎不太完整或有误，翻译时尽量保留了原文形式）
Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. 2022, , 2668.
作者信息
Mansour Amira, Mahmoud Mohamed Y, Bakr Alaa F, Ghoniem Monira G, Adam Fatima A, El-Sherbiny Ibrahim M
机构信息
Nanomedicine Research Labs, Center for Materials Science, Zewail City of Science & Technology, Giza 12578, Egypt.
Department of Toxicology and Forensic Medicine, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
出版信息
Pharmaceutics. 2023 Mar 20;15(3):994. doi: 10.3390/pharmaceutics15030994.
Abstract
In the original publication [...].
摘要
在原始出版物中[...]。
相似文献
1
Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. 2022, , 2668.
Pharmaceutics. 2023 Mar 20;15(3):994. doi: 10.3390/pharmaceutics15030994.
2
Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency.
Pharmaceutics. 2022 Nov 30;14(12):2668. doi: 10.3390/pharmaceutics14122668.
3
Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. 2020, , 2597.
Molecules. 2022 Dec 9;27(24):8730. doi: 10.3390/molecules27248730.
4
Correction: Kazmi et al. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. 2021, , 2086.
Pharmaceutics. 2022 Apr 18;14(4):882. doi: 10.3390/pharmaceutics14040882.
5
Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. 2023, , 682.
Pharmaceutics. 2023 Jun 19;15(6):1769. doi: 10.3390/pharmaceutics15061769.
6
Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. 2019, , 15.
Pharmaceutics. 2023 Aug 24;15(9):2188. doi: 10.3390/pharmaceutics15092188.
7
Correction: Al Khatib et al. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. 2024, , 2777.
Pharmaceutics. 2024 Aug 28;16(9):1136. doi: 10.3390/pharmaceutics16091136.
8
Correction: Zvidzayi et al. A Novel Approach to Assess the Potency of Topical Corticosteroids. 2021, , 1456.
Pharmaceutics. 2022 Sep 22;14(10):2006. doi: 10.3390/pharmaceutics14102006.
9
Correction: Zaman et al. Synthesis and Evaluation of Thiol-Conjugated Poloxamer and Its Pharmaceutical Applications. 2021, , 693.
Pharmaceutics. 2024 May 20;16(5):690. doi: 10.3390/pharmaceutics16050690.
10
Correction: Zare et al. Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics. 2022, , 1620.
Pharmaceutics. 2023 Jan 13;15(1):279. doi: 10.3390/pharmaceutics15010279.
本文引用的文献
1
Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency.
Pharmaceutics. 2022 Nov 30;14(12):2668. doi: 10.3390/pharmaceutics14122668.
Zotero 插件